| - GRCh37:
- Chr1:216348812
- GRCh38:
- Chr1:216175470
| USH2A | L1470fs | Usher syndrome type 2A | Likely pathogenic (Sep 12, 2023) | criteria provided, single submitter |
| - GRCh38:
- Chr1:216190126-216251196
| LOC122152296, LOC132088648, USH2A, USH2A-AS1 | | Usher syndrome type 2A | Likely pathogenic (Aug 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215847736-215847737
- GRCh38:
- Chr1:215674394-215674395
| USH2A | S4506fs | Usher syndrome type 2A | Pathogenic (Jun 26, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr1:216138660-216270555
| USH2A | | Usher syndrome type 2A | Pathogenic (May 26, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr8:22021421
- GRCh38:
- Chr8:22163908
| SFTPC | P101L, P148L, P154L | Usher syndrome type 2A | Uncertain significance (Jul 22, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215987118
- GRCh38:
- Chr1:215813776
| USH2A | H3234fs | Usher syndrome type 2A | Pathogenic (Feb 28, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216256904-216256905
- GRCh38:
- Chr1:216083562-216083563
| USH2A-AS2, USH2A | M1731fs | Usher syndrome type 2A | Pathogenic (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215916617
- GRCh38:
- Chr1:215743275
| USH2A | T3817I | Usher syndrome type 2A | Uncertain significance (Dec 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216138732
- GRCh38:
- Chr1:215965390
| USH2A | W2349* | Usher syndrome type 2A | Pathogenic (Jan 25, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420569
- GRCh38:
- Chr1:216247227
| USH2A | | Usher syndrome type 2A | Likely pathogenic (Oct 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216496897
- GRCh38:
- Chr1:216323555
| USH2A | H490P | Usher syndrome type 2A | Uncertain significance (May 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216498937-216498940
- GRCh38:
- Chr1:216325595-216325598
| USH2A | | Usher syndrome type 2A | Pathogenic (May 6, 2021) | criteria provided, single submitter |
| | USH2A | | Usher syndrome type 2A | Pathogenic (Nov 10, 2022) | criteria provided, single submitter |
| - GRCh38:
- Chr1:216462679-216462739
| USH2A | | Usher syndrome type 2A | Likely pathogenic (Nov 10, 2022) | criteria provided, single submitter |
| - GRCh38:
- Chr1:216108034-216108100
| USH2A | | Usher syndrome type 2A | Likely pathogenic (Nov 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216465714
- GRCh38:
- Chr1:216292372
| USH2A | | Usher syndrome type 2A, not provided | Pathogenic (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216144093
- GRCh38:
- Chr1:215970751
| USH2A | Y2277* | Usher syndrome type 2A | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420006-216420007
- GRCh38:
- Chr1:216246664-216246665
| LOC122152296, USH2A | G910fs | Usher syndrome type 2A | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215847771
- GRCh38:
- Chr1:215674429
| USH2A | Y4494* | Usher syndrome type 2A | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216496971-216496972
- GRCh38:
- Chr1:216323629-216323630
| USH2A | P465fs | Usher syndrome type 2A | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216496866-216496867
- GRCh38:
- Chr1:216323524-216323525
| USH2A | V500fs | Usher syndrome type 2A | Likely pathogenic (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216373295-216373296
- GRCh38:
- Chr1:216199953-216199954
| USH2A, USH2A-AS1 | S1162fs | Usher syndrome type 2A | Likely pathogenic (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420467
- GRCh38:
- Chr1:216247125
| USH2A | K757* | Usher syndrome type 2A | Likely pathogenic (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420211
- GRCh38:
- Chr1:216246869
| LOC122152296, USH2A | F842fs | Usher syndrome type 2A | Likely pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216246257
- GRCh38:
- Chr1:216072915
| USH2A, USH2A-AS2 | W1944* | Usher syndrome type 2A | Likely pathogenic (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216497662-216497668
- GRCh38:
- Chr1:216324320-216324326
| USH2A | S391fs | Usher syndrome type 2A | Likely pathogenic (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216221983
- GRCh38:
- Chr1:216048641
| USH2A | L2019* | Usher syndrome type 2A | Likely pathogenic (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215820994
- GRCh38:
- Chr1:215647652
| USH2A | Y4887* | Usher syndrome type 2A | Likely pathogenic (May 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216497603
- GRCh38:
- Chr1:216324261
| USH2A | W412* | Usher syndrome type 2A | Likely pathogenic (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216500988
- GRCh38:
- Chr1:216327646
| USH2A | Q265* | Usher syndrome type 2A | Likely pathogenic (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216498775-216498776
- GRCh38:
- Chr1:216325433-216325434
| USH2A | A339fs | Usher syndrome type 2A | Likely pathogenic (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216372969
- GRCh38:
- Chr1:216199627
| USH2A, USH2A-AS1 | G1271* | Usher syndrome type 2A | Likely pathogenic (Apr 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216051113
- GRCh38:
- Chr1:215877771
| USH2A | K2890* | Usher syndrome type 2A | Likely pathogenic (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216390805
- GRCh38:
- Chr1:216217463
| USH2A, USH2A-AS1 | T1028fs | Usher syndrome type 2A | Likely pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216373448
- GRCh38:
- Chr1:216200106
| USH2A, USH2A-AS1 | L1111* | Usher syndrome type 2A | Likely pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420311-216420313
- GRCh38:
- Chr1:216246969-216246971
| LOC122152296, USH2A | C808fs | Usher syndrome type 2A | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216496937-216496938
- GRCh38:
- Chr1:216323595-216323596
| USH2A | Q477fs | Usher syndrome type 2A | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420359
- GRCh38:
- Chr1:216247017
| LOC122152296, USH2A | K793* | Usher syndrome type 2A | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216373157
- GRCh38:
- Chr1:216199815
| USH2A, USH2A-AS1 | W1208* | Usher syndrome type 2A | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216061809
- GRCh38:
- Chr1:215888467
| USH2A | Q2728* | Usher syndrome type 2A | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420419
- GRCh38:
- Chr1:216247077
| LOC122152296, USH2A | K773* | Usher syndrome type 2A | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215914802
- GRCh38:
- Chr1:215741460
| USH2A | K3876* | Usher syndrome type 2A | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215848292
- GRCh38:
- Chr1:215674950
| USH2A | E4321* | Usher syndrome type 2A | Likely pathogenic (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216424418
- GRCh38:
- Chr1:216251076
| USH2A | K665fs | Usher syndrome type 2A | Likely pathogenic (Mar 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216371839-216371846
- GRCh38:
- Chr1:216198497-216198504
| USH2A, USH2A-AS1 | Q1298fs | Usher syndrome type 2A | Likely pathogenic (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215847607
- GRCh38:
- Chr1:215674265
| USH2A | L4549* | Usher syndrome type 2A | Likely pathogenic (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216465698
- GRCh38:
- Chr1:216292356
| USH2A | L553fs | Usher syndrome type 2A | Likely pathogenic (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216498792-216498793
- GRCh38:
- Chr1:216325450-216325451
| USH2A | S333fs | Usher syndrome type 2A | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215956085
- GRCh38:
- Chr1:215782743
| USH2A | S3527* | Usher syndrome type 2A | Likely pathogenic (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420285
- GRCh38:
- Chr1:216246943
| LOC122152296, USH2A | C817* | Usher syndrome type 2A | Likely pathogenic (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216373094-216373095
- GRCh38:
- Chr1:216199752-216199753
| USH2A, USH2A-AS1 | L1229fs | Usher syndrome type 2A | Likely pathogenic (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216538344-216538345
- GRCh38:
- Chr1:216365002-216365003
| USH2A | S245fs | Usher syndrome type 2A | Likely pathogenic (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215987210
- GRCh38:
- Chr1:215813868
| USH2A | G3203* | Usher syndrome type 2A | Likely pathogenic (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215847806
- GRCh38:
- Chr1:215674464
| USH2A | G4483* | Usher syndrome type 2A | Likely pathogenic (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216019166
- GRCh38:
- Chr1:215845824
| USH2A | E3019* | Usher syndrome type 2A | Likely pathogenic (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216052361
- GRCh38:
- Chr1:215879019
| USH2A | L2768* | Usher syndrome type 2A | Likely pathogenic (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215956179
- GRCh38:
- Chr1:215782837
| USH2A | E3496* | Usher syndrome type 2A | Likely pathogenic (Feb 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216373262-216373263
- GRCh38:
- Chr1:216199920-216199921
| USH2A, USH2A-AS1 | S1173fs | Usher syndrome type 2A | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216498834
- GRCh38:
- Chr1:216325492
| USH2A | C319fs | Usher syndrome type 2A | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216369939-216369940
- GRCh38:
- Chr1:216196597-216196598
| USH2A, USH2A-AS1 | S1403fs | Usher syndrome type 2A | Likely pathogenic (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420319-216420320
- GRCh38:
- Chr1:216246977-216246978
| LOC122152296, USH2A | T806fs | Usher syndrome type 2A | Likely pathogenic (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215953281
- GRCh38:
- Chr1:215779939
| USH2A | K3615* | Usher syndrome type 2A | Likely pathogenic (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215990530
- GRCh38:
- Chr1:215817188
| USH2A | Q3127* | Usher syndrome type 2A | Likely pathogenic (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216405439-216405442
- GRCh38:
- Chr1:216232097-216232100
| USH2A, USH2A-AS1 | L949fs | Usher syndrome type 2A | Likely pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216538421
- GRCh38:
- Chr1:216365079
| USH2A | Q220* | Usher syndrome type 2A | Likely pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216270532
- GRCh38:
- Chr1:216097190
| USH2A | K1551* | Usher syndrome type 2A | Likely pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216405324-216405326
- GRCh38:
- Chr1:216231982-216231984
| USH2A, USH2A-AS1 | H988fs | Usher syndrome type 2A | Likely pathogenic (Jan 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216052431
- GRCh38:
- Chr1:215879089
| USH2A | K2745* | Usher syndrome type 2A | Likely pathogenic (Jan 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216405411-216405412
- GRCh38:
- Chr1:216232069-216232070
| USH2A, USH2A-AS1 | V959fs | Usher syndrome type 2A | Likely pathogenic (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216390811-216390814
- GRCh38:
- Chr1:216217469-216217472
| USH2A, USH2A-AS1 | K1024fs | Usher syndrome type 2A | Likely pathogenic (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215848260
- GRCh38:
- Chr1:215674918
| USH2A | Y4331* | Usher syndrome type 2A | Likely pathogenic (Jan 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420267-216420268
- GRCh38:
- Chr1:216246925-216246926
| LOC122152296, USH2A | R824fs | Usher syndrome type 2A | Likely pathogenic (Jan 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216420053
- GRCh38:
- Chr1:216246711
| LOC122152296, USH2A | Q895* | Usher syndrome type 2A | Likely pathogenic (Jan 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216371738
- GRCh38:
- Chr1:216198396
| USH2A, USH2A-AS1 | K1334* | Usher syndrome type 2A | Likely pathogenic (Jan 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216243590
- GRCh38:
- Chr1:216070248
| USH2A | G1968* | Usher syndrome type 2A | Likely pathogenic (Nov 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215933134
- GRCh38:
- Chr1:215759792
| USH2A | L3700* | Usher syndrome type 2A | Likely pathogenic (Jan 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216496927-216496931
- GRCh38:
- Chr1:216323585-216323589
| USH2A | F479fs | Usher syndrome type 2A | Likely pathogenic (Jan 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215847952
- GRCh38:
- Chr1:215674610
| USH2A | S4434* | Usher syndrome type 2A | Likely pathogenic (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216390803-216390804
- GRCh38:
- Chr1:216217461-216217462
| USH2A, USH2A-AS1 | T1028fs | Usher syndrome type 2A | Likely pathogenic (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216019361
- GRCh38:
- Chr1:215846019
| USH2A | Q2954* | Usher syndrome type 2A | Likely pathogenic (Jan 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216371901
- GRCh38:
- Chr1:216198559
| USH2A, USH2A-AS1 | | Usher syndrome type 2A | Pathogenic (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216380774
- GRCh38:
- Chr1:216207432
| USH2A, USH2A-AS1 | | Usher syndrome type 2A | Likely pathogenic (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216061850
- GRCh38:
- Chr1:215888508
| USH2A | W2714* | Usher syndrome type 2A | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216592023
- GRCh38:
- Chr1:216418681
| USH2A | | Usher syndrome type 2A | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215848545
- GRCh38:
- Chr1:215675203
| USH2A | C4236* | Usher syndrome type 2A | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216595277-216595278
- GRCh38:
- Chr1:216421935-216421936
| USH2A | S134fs | Usher syndrome type 2A | Pathogenic (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215820972
- GRCh38:
- Chr1:215647630
| USH2A | S4895G | Usher syndrome type 2A | Uncertain significance (May 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216052184
- GRCh38:
- Chr1:215878842
| USH2A | L2827* | Usher syndrome type 2A | Likely pathogenic (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216262382
- GRCh38:
- Chr1:216089040
| USH2A | Q1620* | Usher syndrome type 2A | Likely pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215814033
- GRCh38:
- Chr1:215640691
| USH2A | V4946fs | Usher syndrome type 2A | Pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215847941
- GRCh38:
- Chr1:215674599
| USH2A | W4438R | not specified, Retinitis pigmentosa 39, Usher syndrome type 2A
| Uncertain significance (Mar 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216371804
- GRCh38:
- Chr1:216198462
| USH2A, USH2A-AS1 | A1312fs | Usher syndrome type 2A | Pathogenic (Oct 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216270450
- GRCh38:
- Chr1:216097108
| USH2A | R1578H | Retinitis pigmentosa 39, Usher syndrome type 2A, not provided
| Uncertain significance (Jul 2, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215848937
- GRCh38:
- Chr1:215675595
| USH2A | G4106R | Usher syndrome type 2A, Retinitis pigmentosa 39, not provided
| Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216363657
- GRCh38:
- Chr1:216190315
| USH2A | K1435T | Usher syndrome type 2A, Retinitis pigmentosa 39, not provided
| Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:215960134
- GRCh38:
- Chr1:215786792
| USH2A | S3422N | Usher syndrome type 2A, not provided | Uncertain significance (Dec 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215933027
- GRCh38:
- Chr1:215759685
| USH2A | D3736N | not provided, Retinitis pigmentosa 39, Usher syndrome type 2A
| Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:102783795
- GRCh38:
- Chr10:101024038
| PDZD7 | S86L | Usher syndrome type 2C, Usher syndrome type 2A, Hearing loss, autosomal recessive 57, not provided | Uncertain significance (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216143966
- GRCh38:
- Chr1:215970624
| USH2A | | Retinitis pigmentosa 39, Usher syndrome type 2A, not provided
| Likely pathogenic (Jul 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215972394
- GRCh38:
- Chr1:215799052
| USH2A | M3271I | Usher syndrome type 2A, Retinitis pigmentosa 39, not provided
| Uncertain significance (Aug 11, 2022) | criteria provided, multiple submitters, no conflicts |